Page last updated: 2024-11-02

4-phenylbutyric acid and Arteriosclerosis

4-phenylbutyric acid has been researched along with Arteriosclerosis in 2 studies

4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.

Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KRITCHEVSKY, D1
MOYER, AW1
TESAR, WC1
MCCANDLESS, RF1
LOGAN, JB1
BROWN, RA1
ENGLERT, M1
ZENI, G1

Other Studies

2 other studies available for 4-phenylbutyric acid and Arteriosclerosis

ArticleYear
The effect of sodium 2-phenylbutyrate in experimental atherosclerosis.
    Angiology, 1956, Volume: 7, Issue:2

    Topics: Arteriosclerosis; Atherosclerosis; Butyrates; Phenylbutyrates; Sodium

1956
[Sodium phenylbutyrate in the treatment of arteriosclerotic disease].
    Gazzetta medica italiana, 1958, Volume: 117, Issue:12

    Topics: Arteriosclerosis; Humans; Phenylacetates; Phenylbutyrates; Sodium

1958